Aethlon Medical Inc - Asset Resilience Ratio
Aethlon Medical Inc (AEMD) has an Asset Resilience Ratio of 0.00% as of September 2018. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See AEMD current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2014–2018)
This chart shows how Aethlon Medical Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see AEMD current and non-current assets.
Liquid Assets Composition Over Time
This chart breaks down Aethlon Medical Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read how much debt does Aethlon Medical Inc carry for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: Aethlon Medical Inc maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
Aethlon Medical Inc Industry Peers by Asset Resilience Ratio
Compare Aethlon Medical Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 5.73% |
|
LENSAR Inc
NASDAQ:LNSR |
Medical Devices | 0.00% |
|
Lumos Diagnostics Holdings Ltd
AU:LDX |
Medical Devices | 14.18% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
DRTECH Corporation
KQ:214680 |
Medical Devices | 5.18% |
|
MODULIGHT OY EO 1
F:78W |
Medical Devices | 15.99% |
Annual Asset Resilience Ratio for Aethlon Medical Inc (2014–2018)
The table below shows the annual Asset Resilience Ratio data for Aethlon Medical Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2018-03-31 | 0.00% | $0.00 | $7.35 Million | -- |
| 2017-03-31 | 0.00% | $0.00 | $1.73 Million | -- |
| 2016-03-31 | 0.00% | $0.00 | $2.56 Million | -- |
| 2014-03-31 | 0.00% | $0.00 | $1.70 Million | -- |
About Aethlon Medical Inc
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states. The company was founded in 1984 and is based in San Diego, California.